
Twelve years of multiples investors have paid for Religare Enterprises Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Religare Enterprises Ltd trades at a P/E of 95.22× and P/B of 2.81×, against the Financial Services sector median P/E of 18.34×.
Twelve years of audited numbers for Religare Enterprises Ltd, switchable between annual and quarterly views, consolidated or standalone.
Religare Enterprises Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹8,288.97 Cr and reported EPS of ₹2.58.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,346 | 2,355 | 2,487 | 3,224 | 4,676 | 6,235 | 7,354 | 8,459 |
| Other Income | 55 | 42 | 44 | 149 | 187 | 64 | 43 | 34 |
| Total Income | 2,402 | 2,397 | 2,530 | 3,372 | 4,863 | 6,299 | 7,397 | 8,494 |
| Gross Profit | 2,346 | 2,355 | 2,487 | 3,224 | 4,676 | 6,235 | 7,354 | 8,459 |
| +Operating Expenses | 1,700 | 1,926 | 2,061 | 3,037 | 3,769 | 4,626 | 5,669 | 6,821 |
| EBITDA | 646 | 430 | 426 | 186 | 908 | 1,609 | 1,685 | 1,639 |
| +Non-Operating Expenses | 876 | 740 | 784 | 793 | 3,974 | 396 | 99 | 83 |
| Profit Before Tax (PBT) | -1,503 | -1,030 | -497 | -1,031 | 3,259 | 448 | 243 | 87 |
| +Tax Expense | -3 | 8 | -20 | 507 | 90 | 100 | 60 | 14 |
| Profit After Tax (PAT) | -1,501 | -1,038 | -478 | -1,539 | 3,169 | 347 | 183 | 73 |
| Earnings Per Share (EPS) | -59.33 | -36.12 | -19.60 | -48.26 | 95.24 | 7.06 | 3.79 | 2.58 |
| Diluted Shares Outstanding (Nos.) | 22 | 26 | 26 | 32 | 32 | 33 | 33 | 33 |
| +Banking Income | 2,402 | 2,397 | 2,530 | 3,372 | 4,863 | 6,299 | 7,397 | 8,494 |
| +Additional Disclosures | 3,695 | 3,166 | 3,087 | 4,370 | 4,904 | 6,251 | 7,280 | 8,284 |
| Sales Growth % | — | 0.38 | 5.58 | 29.63 | 45.07 | 33.32 | 17.95 | 15.03 |
| YoY Sales Growth % | — | 0.38 | 5.58 | 29.63 | 45.07 | 33.32 | 17.95 | 15.03 |
| Employee Cost % | 22 | 23 | 24 | 25 | 20 | 17 | 15 | 14 |
| Other Cost % | 50 | 59 | 59 | 69 | 61 | 57 | 62 | 66 |
| OPM % | 28 | 18 | 17 | 6 | 19 | 26 | 23 | 19 |
| Tax % | 0 | -1 | 4 | -49 | 3 | 22 | 25 | 16 |
| Profit Growth % | — | 30.85 | 53.97 | -221.99 | 305.95 | -89.04 | -47.23 | -60.09 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| +Additional Fields | — | 46 | 89 | 183 | 509 | 1,161 | 1,446 | 1,549 |
Disclosed business segments at Religare Enterprises with their share of revenue and profit, switchable between consolidated and standalone reporting.
Religare Enterprises discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Religare Enterprises Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Religare Enterprises Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
Very low debt-to-equity ratio (0.09) indicates strong financial health.
Consistent positive quarterly sales growth of 8.88% reflects market demand.
Promoter holding increased to 25.83%, signaling renewed stakeholder confidence.
Strong historical revenue growth with 5Y CAGR of 25.57%.
Diversified financial services portfolio across broking, insurance, e-governance.
High P/E ratio (74.30) and low ROE (5.15%) raise valuation concerns.
Significant quarterly profit decline of -42.90% indicates recent operational challenges.
Zero dividend yield (0.00%) may deter income-focused investors.
Negative EPS growth over TTM (-37.24%) and Qtr YoY (-42.59%).
Declining FII holding from 19.60% to 7.81% signals waning foreign confidence.
Trim if P/E re-rates above 124 (~6.8× the sector multiple of 18.3). The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 13.22. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Religare Enterprises Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Religare Enterprises Ltd — derived from the live tape, not yesterday's close.
Religare Enterprises Ltd last traded at ₹247.63 with an intraday range of ₹244.4–₹253.61 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 271.11 | +23.48 | +9.48% |
| R3 | 261.90 | +14.27 | +5.76% |
| R2 | 257.76 | +10.13 | +4.09% |
| R1 | 252.69 | +5.06 | +2.04% |
| PIVOT | 248.55 | 0.92 | 0.37% |
| CURRENT | 247.63 | — | — |
| S1 | 225.06 | -22.57 | -9.11% |
| S2 | 234.27 | -13.36 | -5.39% |
| S3 | 239.34 | -8.29 | -3.35% |
| S4 | 243.48 | -4.15 | -1.67% |
RELIGARE is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 244.81 ~ 252
Trading Inside opening range
Auto-detected classical chart patterns for Religare Enterprises Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Daily traded volume and delivery percentage for Religare Enterprises Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Religare Enterprises Ltd stood at 56.9% of traded volume, against a 20-day average of 57.5%.
Filings Religare Enterprises sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Religare Enterprises files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 158 documents below.
Religare Enterprises Limited has informed the Exchange about Copy of Newspaper Publication in form INC-26
Religare Enterprises Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on May 05, 2026
Religare Enterprises Limited has informed the Exchange about General Updates
Religare Enterprises Limited has informed the Exchange about General Updates w.r.t Cessation of Mr. Anuj Gulati as MD & CEO of Care Health Insurance…
Religare Enterprises Limited has informed the Exchange about General Updates w.r.t Appointment of Mr. Manish Vishnu Dodeja as Whole Time Director of…
Promoter, director and designated-employee transactions in Religare Enterprises as reported to SEBI — buying and selling signals from the people who know the business best.
Religare Enterprises insider activity below tracks 15 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Gyan Enterprises Private limited | Insider | 27 Mar 2026 | buy | +13.27 L | ₹29.79 Cr | ₹224.49 |
| Gyan Enterprises Private limited | Insider | 27 Mar 2026 | buy | +13.27 L | ₹29.79 Cr | ₹224.49 |
| Gyan Enterprises Private limited | Insider | 27 Mar 2026 | buy | +13.27 L | ₹29.79 Cr | ₹224.49 |
| Gyan Enterprises Private limited | Insider | 27 Mar 2026 | buy | +13.27 L | ₹29.79 Cr | ₹224.49 |
| SHIVANI BURMAN | Insider | 16 Mar 2026 | buy | +6.07 L | ₹13.37 Cr | ₹220.04 |
| SHIVANI BURMAN | Insider | 16 Mar 2026 | buy | +6.07 L | ₹13.37 Cr | ₹220.04 |
| SHIVANI BURMAN | Insider | 16 Mar 2026 | buy | +6.07 L | ₹13.37 Cr | ₹220.04 |
| SHIVANI BURMAN | Insider | 16 Mar 2026 | buy | +6.07 L | ₹13.37 Cr | ₹220.04 |
| SHIVANI BURMAN | Insider | 13 Mar 2026 | buy | +13.49 L | ₹29.48 Cr | ₹218.58 |
| SHIVANI BURMAN | Insider | 13 Mar 2026 | buy | +13.49 L | ₹29.48 Cr | ₹218.58 |
Every dividend, stock split and bonus issue Religare Enterprises has declared, sequenced by announce and record date.
Religare Enterprises corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Religare Enterprises Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Religare Enterprises Ltd operates in the Financial Services, listed as NSE: RELIGARE, BSE: 532915.

Religare Enterprises Limited is a diversified financial services company operating primarily in India, with some international reach. Its business model encompasses a wide range of activities spanning investment and financing, broking, e-governance, and insurance. This broad portfolio allows them to cater to a diverse clientele, from individual consumers to corporations.
A significant portion of Religare's business involves financing, particularly for small and medium-sized enterprises (SMEs). They provide crucial financial support to these businesses, and also offer a suite of housing finance products including home purchase, construction, and improvement loans. This aspect contributes substantially to their revenue and plays a key role in supporting India's economic growth.
The company also has a substantial presence in the broking sector, offering services related to equities, currency, and commodities. This allows them to participate in the dynamism of the Indian financial markets, acting as an intermediary for investors and traders. Furthermore, their role as a depository participant and an Aadhaar enrolment agency highlights their involvement in essential financial and administrative infrastructure.
Religare's insurance segment offers a comprehensive range of products, including health, critical illness, personal accident, and travel insurance for individuals. They also cater to corporate clients by offering group health and personal accident insurance plans. This diversified approach to insurance provides them with a stable revenue stream and allows them to address a broad spectrum of risk management needs.
Beyond core financial services, Religare is involved in e-governance initiatives. These include services such as PAN issuance, tax collection and return filing, and acting as a business correspondent for banking services. They also offer various other services like bill payments, ticketing, digital signature certificates, and central record-keeping agency facilitation. This diversification broadens their market reach and provides additional revenue streams.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Religare Enterprises Ltd (RELIGARE) is ₹247.63. Today, the stock has gained by ₹1.95 (0.79%), trading in a range of ₹244.4 to ₹253.61. The stock opened at ₹245 with a trading volume of 22,46,435 shares.
Religare Enterprises Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹8,288.97 crores, P/E ratio of 95.22, ROE of 2.00%, and ROCE of 8.39%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Religare Enterprises Ltd (RELIGARE) is ₹295, while the 52-week low is ₹196.51. Currently trading at ₹247.63, the stock is 51.9% away from its 52-week low and 16.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Religare Enterprises Ltd stock at ₹247.63 depends on multiple factors. The stock is currently trading with a P/E ratio of 95.22 and P/B ratio of 2.81. Today's performance shows a gain of 0.79%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Religare Enterprises Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹247.63, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Religare Enterprises Ltd's key financial metrics include: P/E Ratio: 95.22, P/B Ratio: 2.81, ROE: 2.00%, ROCE: 8.39%, Dividend Yield: 0.00%, EPS: ₹2.58, Book Value: ₹87.38, and Debt-to-Equity: 12.72. The company's market cap stands at ₹8,288.97 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Religare Enterprises Ltd stock opened at ₹245 and is currently trading at ₹247.63, showing a gain of ₹1.95 (0.79%). The intraday high is ₹253.61 and low is ₹244.4. The trading volume stands at 22,46,435 shares, indicating strong market participation today.
Religare Enterprises Ltd has a Price-to-Earnings (P/E) ratio of 95.22, which means investors are willing to pay ₹95.22 for every ₹1 of earnings. With an EPS of ₹2.58, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Religare Enterprises Ltd (RELIGARE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.